ACE2 the Janus-faced protein – from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19-Reference-Cited by-同舟云学术

ACE2 the Janus-faced protein – from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19

Published:2020-04 Issue:7 Volume:134 Page:747-750
ISSN:0143-5221
Container-title:Clinical Science
language:en
Short-container-title:

Author:

Touyz Rhian M.¹^ORCID,Li Hongliang²,Delles Christian¹^ORCID

Affiliation:

1. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.

2. Department of Cardiology, Renmin Hopsital of Wuhan University, Institute of Model Animal of Wuhan University, Wuhan, China

Abstract

Abstract Angiotensin converting enzyme 2 (ACE2) is the major enzyme responsible for conversion of Ang II into Ang-(1-7). It also acts as the receptor for severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2, which causes Coronavirus Disease (COVID)-19. In recognition of the importance of ACE2 and to celebrate 20 years since its discovery, the journal will publish a focused issue on the basic science and (patho)physiological role of this multifunctional protein.

Publisher

Portland Press Ltd.

Subject

General Medicine

Link

https://portlandpress.com/clinsci/article-pdf/134/7/747/871282/cs-2020-0363.pdf

Reference36 articles.

1. The renin-angiotensin system: going beyond the classical paradigms;Santos;Am. J. Physiol. Heart Circ. Physiol.,2019

2. Classic and nonclassic renin-angiotensin systems in the critically ill;Bitker;Crit. Care Clin.,2019

3. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9;Donoghue;Circ. Res.,2000

4. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase;Tipnis;J. Biol. Chem.,2000

5. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors;Turner;Can. J. Physiol. Pharmacol.,2002

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reviewing the insights of SARS-CoV-2: Its epidemiology, pathophysiology, and potential preventive measures in traditional medicinal system;Clinical Traditional Medicine and Pharmacology;2024-06

2. COVID-19: Natural History and Spectrum of Disease;Textbook of SARS-CoV-2 and COVID-19;2024

3. Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19;Current Neuropharmacology;2023-10

4. A Narrative Review of Non-Pharmacological Strategies for Managing Sarcopenia in Older Adults with Cardiovascular and Metabolic Diseases;Biology;2023-06-21

5. Efficacy of N-acetyl Cysteine in Severe COVID-19 Patients: A Randomized Controlled Phase III Clinical Trial;Jundishapur Journal of Natural Pharmaceutical Products;2023-01-13